Ishihara Tetsuro, Ito Mizuki, Niimi Yoshiki, Tsujimoto Masashi, Senda Jo, Kawai Yoshinari, Watanabe Hirohisa, Ishigami Masatoshi, Ito Takashi, Kamei Hideya, Onishi Yasuharu, Nakamura Taro, Goto Hidemi, Naganawa Shinji, Kiuchi Tetsuya, Sobue Gen
Department of Neurology, Yokkaichi Municipal Hospital, Mie, Japan.
Clin Neurol Neurosurg. 2013 Nov;115(11):2341-7. doi: 10.1016/j.clineuro.2013.08.015. Epub 2013 Sep 10.
To elucidate the effect of liver transplantation (LT) on brain dysfunctions in cirrhotic patients who had no clinical evidence of hepatic encephalopathy (HE), we performed a prospective study of voxel-based diffusion tensor imaging (DTI) and detailed cognitive examination.
We assessed 12 consecutive patients as transplant candidates by DTI, with neurological and cognitive examinations just before and at 6 months after LT.
After LT, cirrhotic patients showed significant improvement in visual reproduction, digit symbol, digit span, Stroop test, and Trail-making test scores, suggesting recovery of frontal-temporal function. As for voxel-based DTI, increased mean diffusivity (MD) and reduced fractional anisotropy (FA) values were found before LT in the frontal and temporal lobes of cirrhotic patients. After LT, the unusual FA and MD values observed in the frontal and temporal lobes preoperatively were significantly reduced.
End-stage cirrhotic patients without clinical evidence of HE showed increased MD and decreased FA values in both frontal and temporal lobes. These parameters improved after LT, in line with cognitive function. MD and FA values might be of value as a biomarker in end-stage cirrhotic patients for investigating brain tissue dysfunctions and evaluating the efficacy of LT.
为阐明肝移植(LT)对无肝性脑病(HE)临床证据的肝硬化患者脑功能障碍的影响,我们进行了一项基于体素的扩散张量成像(DTI)前瞻性研究及详细的认知检查。
我们通过DTI对12例连续的肝移植候选患者进行评估,并在LT前及LT后6个月进行神经学和认知检查。
LT后,肝硬化患者在视觉再现、数字符号、数字广度、斯特鲁普测验和连线测验分数方面有显著改善,提示额颞叶功能恢复。对于基于体素的DTI,肝硬化患者在LT前额叶和颞叶的平均扩散率(MD)增加,分数各向异性(FA)值降低。LT后,术前在额叶和颞叶观察到的异常FA和MD值显著降低。
无HE临床证据的终末期肝硬化患者额叶和颞叶的MD值增加,FA值降低。LT后这些参数得到改善,与认知功能一致。MD和FA值可能作为生物标志物,用于研究终末期肝硬化患者的脑组织功能障碍及评估LT的疗效。